Papers & Talks

GENERAL PUBLIC PRESENTATIONS

CanCan Health Ovarian & Breast Education Party, presented on personal experience of surviving breast cancer to bring awareness around signs, symptoms and self-advocacy, March 2017 – present.

Big Climb Lab Crawl, presented research findings to donors who participate in Big Climb to raise money for Fred Hutch research, Seattle, WA, January 2016. (Invited Speaker)

FHCRC New Employee Orientations, communicate scientific research in lay-person accessible manner to incoming scientific and administrative staff, Seattle, WA, July 2011 to November 2016. (Invited Speaker)

Hutch Gala Fundraising Discussions, Informal conversations regarding FHCRC and research with potential donors, Seattle, WA, December, 2014 and 2015. (Invited Participant)

Social Media and Adolescent Health Research Team (SMAHRT) Conference: Using Social Media to Promote and Disseminate your research Findings, Seattle, WA, July 2014 (Invited Speaker/Panelist)

Science for Staff, Presentation for administrative and scientific staff on ongoing research, FHCRC, Seattle, WA, May 2014 (Invited Speaker)

FHCRC Information Technology Staff Meeting, presented scientific research in lay-person accessible manner to all Information Technology Department staff, Seattle, WA, April 2013. (Invited Speaker)

Panel Moderator and Organizer—The Keys to Success: More than just surviving a Ph.D., SACNAS National Conference, Seattle, WA, October 2012.

Innovator’s Network for Fundraising, presented scientific research in lay-person accessible manner to current and potential donors for the FHCRC, Seattle, WA, September 2011. (Invited Speaker)

Science over Lunch, presented scientific research in lay-person accessible manner to donors for the FHCRC, Seattle, WA, June 2011. (Invited Speaker)


 

SCIENTIFIC PUBLICATIONS

Jacquemont, C., Dhillon, K.K., Castella, M., and Taniguchi, T., USP28 is a downstream effector of 53BP1 that inhibits DNA end-resection and homologous recombination (In Preparation)

Calses, P.C., Dhillon, K.K., Huang, J-W., Kawasumi, M., Nghiem, P., Wang, Y., Jacquemont, C., Gafken, P.R., Sugasawa, K., Saijo, M., and Taniguchi, T. (2017) DGCR8 mediates repair of UV-induced DNA damage independently of RNA processing, Cell Reports, 19: 162-174.

Dhillon, K.K., Bajrami, I., Lord, C., and Taniguchi, T. (2016) Synthetic lethality – the road to novel therapies for breast cancer. Endocrine-Related Cancers, 23: 39-55.

Drost, R., Dhillon, K.K., van der Gulden, H., van der Heijden, I., Brandsma, I., Cruz, C., Chondranasiou, D., Castroviejo-Bermejo, M., Boon, U., Schut, E., van der Burg, E., Wientjens, E., Pieterse, M., Klijn, C., Klarenbeek, S., Loayza-Puch, F., Elkon, R., van Deemter, L., Rottenberg, S., van de ven, M., Dekkers, D.H.W., Demmers, J.A.A., van Gent, D.C., Agami, R., Balmana, J., Serra, V., Taniguchi, T., Bowman, P., and Jonkers, J. (2016) BRCA1-185delAG tumors may acquire therapy resistance through expression of RING-less BRCA1. Journal of Clinical Investigation126: 2903-18.

Dhillon, K.K. and Taniguchi, T. (2015) Resistance to PARP Inhibitors Mediated by Secondary BRCA1/2 Mutations. In Curtin, N. and Sharma, R (Eds.). PARP Inhibitors for Cancer Therapy, Cancer Drug Discovery and Development. Springer International Publishing.

Huang, J.W., Wang, Y., Dhillon, K.K., Calses, P., Villegas, E., Mitchell, P.S., Tewari, M., Kemp, C.J., and Taniguchi, T. (2013) Systematic Screen Identifies miRNAs that Target RAD51 and RAD51D to Enhance Chemosensitivity. Molecular Cancer Research, 11: 1564:73.

Taniguchi, T., Dhillon, K. K., Castella, M., Cheung, R. S., and Jacquemont, C. (2011) Fanc/Bloom-opathies: Recent progress in molecular pathogenesis of Fanconi anemia and its connection to Bloom syndrome. In E.C. Friedberg, D. H. Castrillon, R. L. Galindo, and K. Wharton (Eds.). New-opathies: An Emerging Molecular Reclassification of Human Disease. World Scientific Publishing Company; 1st edition.

Dhillon K. K., Swisher, E. M., Taniguchi, T. (2010) Secondary mutations of BRCA1/2 and drug resistance.Cancer Science, 102, 663-669.

Dhillon, K.K., Sidorova, J., Albertson, T., Anderson, J., Ladiges, W., Rabinovitch, P., Preston, B.D., and Monnat, R. J., Jr. (2010) Divergent cellular phenotypes of human and mouse cells lacking the Werner syndrome RecQ helicase. DNA Repair9: 11-22.

Dhillon, K.K., Sidorova, J., Saintigny, Y., Poot, M., Gollahon, K., Rabinovitch, P. S., Monnat, R. J., Jr. (2007). Functional role of the Werner syndrome RecQ helicase in human fibroblasts, Aging Cell, 6: 53-61.

Ahmed Z.M., Li, X.C., Powell, S.D., Riazuddin, S., Young, T-L., Ramzan, K., Ahmad, Z., Luscombe, S., Dhillon, K., MacLaren, L., Ploplis, B., Shotland, L.I., Ives, E., Riazuddin, S., Friedman, T.B., Morell, R.J., and Wilcox, E.R. (2004). Characterization of a new full length TMPRSS3 isoform and identification of mutant alleles responsible for nonsyndromic recessive deafness in Newfoundland and Pakistan, BMC Medical Genetics5:24-31.


 

SCIENTIFIC PRESENTATIONS

Social Media and Adolescent Health Research Team (SMAHRT) Conference: Using Social Media to Promote and Disseminate your research Findings, Seattle, WA, July 2014 (Invited Speaker/Panelist)

63nd Annual American Society of Human Genetics Meeting: Identification of novel mechanisms of drug resistance in BRCA1-deficient cancer cells by exome and RNA sequencing, Boston, MA, October 2013 (Poster Presentation)

Ataxia-Telangiectasia/Genome Instability Satellite Meeting at the American Society of Human Genetics Annual Meeting: Identification of novel mechanisms of drug resistance in BRCA1-deficient cancer by exome and RNA sequencing, Boston, MA, November 2013 (Invited Speaker)

Howard Hughes Medical Institute Annual Meeting: Identification of novel mechanisms of drug resistance in BRCA1-deficient cancer by exome and RNA sequencing, Chevy Chase, MD, November 2013 (Poster Presentation)

Breast Cancer Research Institute: Identification of chemoresistance mechanisms in BRCA-deficient breast cancer using genomic approaches, Seattle, WA, June 2013 (Invited Speaker)

62nd Annual American Society of Human Genetics Meeting: Identification of novel mechanisms of drug resistance in BRCA1-deficient cancer by exome and RNA sequencing, San Francisco, CA, November 2012 (Invited Speaker)

Ataxia-Telangiectasia/Genome Instability Satellite Meeting at the American Society of Human Genetics Annual Meeting: Identification of novel mechanisms of drug resistance in BRCA1-deficient cancer by exome and RNA sequencing, San Francisco, CA, November 2012 (Invited Speaker)

Keystone Symposium on Genetic Instability and DNA Repair: Mechanisms of cisplatin resistance in BRCA1-deficient cancer cellsKeystone, CO, February 2011. (Poster Presentation)

Fanconi Anemia Research Fund: Mechanisms of cisplatin resistance in BRCA-deficient cancer cellsMinneapolis, MN, October 2010 (Poster Presentation)

Cancer Biology Seminar: Mechanisms of cisplatin resistance in BRCA-deficient cancer cells, Fred Hutchinson Cancer Research Center, Seattle, WA, May 2011 (Oral Presentation)

Basic Sciences and Human Biology Seminar: Mechanisms of Cisplatin Resistance in BRCA1-deficient cells, Fred Hutchinson Cancer Research Center, Seattle, WA, June 2010 (Oral Presentation)

BRCA: Fifteen Years of Progress, The Third International Symposium on Hereditary Breast and Ovarian Cancer, Hereditary Breast and Ovarian Cancer Foundation, Montreal, QC, Canada, October 2009 (Poster Presentation)

Cell and Molecular Biology of Human Disease: Werner syndrome, senior seminar course taught by Dr. Charles Laird, University of Washington, Seattle, WA, November 2007. (Invited Speaker)

Introductions to Genetics: Applications and Ethics presentation to six high school biology classes, Walnut Grove Secondary, Langley, BC, Canada, May 2007. (Invited Speaker)

Cell and Molecular Biology of Human Disease: Werner syndrome, senior seminar course taught by Dr. Charles Laird, University of Washington, Seattle, WA, October 2006. (Invited Speaker)

Genetic Recombination Workshop: Mechanisms, Evolution, and Human Biology, Seattle, WA, May 2006. (Invited Speaker)

Environmental Mutagen Society-Satellite Meeting: Cell Lineages, Genetic Instability and Human Disease, Seattle, WA, August 2005. (Poster Presentation)

FASEB Summer Research Conference: Genetic Recombination and Genomic Rearrangements, Snowmass, CO, July 2005. (Poster Presentation)

Scientist, Communicator, Innovator